Janssen announces new group targeting unmet global health needs

Thursday, January 23, 2014

Janssen, the pharmaceutical companies of Johnson & Johnson, today announced the formation of Janssen Global Public Health (Janssen GPH), an important new group unifying Janssen’s commitment to research, develop, and deliver transformational medicines to address the world’s greatest unmet public health needs. Janssen GPH will align the company’s groundbreaking science and innovative access models under a single entity to drive better health outcomes, improve quality of life for patients, and sustainably advance health for people all over the world.

Source: European Pharmaceutical Review (link opens in a new window)

Categories
Education, Health Care
Tags
global health, medical supply chains, pharmaceutical industry, research